Website intended for a NZ health professional readership
Occupational health expert David McBride discusses the agents behind occupational asthma, including isocyanates used in the construction and painting industries
1. Figley KD, Elrod RH. Endemic asthma due to castor bean dust. JAMA 1928;90(2):79–82.
2. Glass WI, Power P, Burt R, et al. Work-related respiratory symptoms and lung function in New Zealand mussel openers. Am J Ind Med 1998;34(2):163–68.
3. Neitzel JJ. Enzyme catalysis: The serine proteases. Nature Education 2010;3(9):21.
4. Pawlak M, Pobłocki K, Drzeżdżon J, et al. Isocyanates and isocyanides – life-threatening toxins or essential compounds? Sci Total Environ 2024;934:173250.
5. Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002;2(2-3):213–24.
6. Sabbioni G, Pugh SA. New method to biomonitor workers exposed to 1,6-hexamethylene diisocyanate. Chem Res Toxicol 2022;35(12):2285–95.
7. WorkSafe. Isocyanates WES Proposal to change. 7 May 2024.
8. New Zealand Paint Manufacturers Association Incorporated. Isocyanates. 2024.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
